Description
BSE notifies the listing and admission for trading of further securities issued by 10 companies under ESOP/ESOS schemes, effective from October 21, 2025.
Summary
BSE has informed trading members that further securities issued by 10 companies under their Employee Stock Option Plan (ESOP) or Employee Stock Option Scheme (ESOS) have been listed and admitted for trading on the Exchange effective from Tuesday, October 21, 2025. The circular covers a total of 1,023,195 shares across multiple companies with varying face values, and none of the shares are subject to lock-in periods.
Key Points
- 10 companies have issued further securities under ESOP/ESOS schemes
- Total of 1,023,195 shares being listed across all companies
- Effective date for trading: October 21, 2025
- No lock-in period applicable for any of the listed securities
- Companies span banking, pharmaceuticals, technology, exports, and finance sectors
- Largest issuance: Sai Life Sciences Limited (429,000 shares with face value ₹1)
- Second largest: AU Small Finance Bank Limited (160,556 shares with face value ₹10)
- All shares have been assigned distinct ISIN codes and distribution number ranges
Regulatory Changes
No regulatory changes announced. This is a standard listing notification.
Compliance Requirements
- Trading members must note the new securities are available for trading from October 21, 2025
- Members should ensure their systems reflect the updated share capital for the affected companies
- Standard trading rules and regulations apply to these newly listed securities
Important Dates
- Notice Date: October 20, 2025
- Effective Trading Date: October 21, 2025 (Tuesday)
Impact Assessment
Market Impact: Minimal. The issuance represents routine ESOP/ESOS allotments that are expected corporate actions. The share quantities are relatively small compared to the free float of most listed companies.
Dilution Impact: Minor dilution to existing shareholders across the 10 companies, with percentages varying by company size. ICICI Bank has the highest number of shares (125,223) but given its large capital base, the dilution is negligible.
Liquidity Impact: Neutral to slightly positive. Additional shares in circulation may marginally improve liquidity, though the absence of lock-in periods means employees can trade immediately.
Sector Distribution: Diversified across banking (AU Small Finance Bank, AXIS Bank, ICICI Bank), finance (IIFL Finance), pharmaceuticals (Jagsonpal, Poly Medicure, Sai Life Sciences), technology (Onward Technologies), exports (Gokaldas Exports), and trading (Renaissance Global).
Company-wise Details
| Company | Scrip Code | Shares | Face Value (₹) | ISIN |
|---|---|---|---|---|
| AU Small Finance Bank Limited | 540611 | 160,556 | 10 | INE949L01017 |
| AXIS Bank Ltd. | 532215 | 26,763 | 2 | INE238A01034 |
| Gokaldas Exports Ltd | 532630 | 11,500 | 5 | INE887G01027 |
| ICICI Bank Ltd. | 532174 | 125,223 | 2 | INE090A01021 |
| IIFL Finance Limited | 532636 | 111,433 | 2 | INE530B01024 |
| Jagsonpal Pharmaceuticals Limited | 507789 | 93,445 | 2 | INE048B01035 |
| Onward Technologies Ltd. | 517536 | 6,500 | 10 | INE229A01017 |
| Poly Medicure Ltd | 531768 | 33,775 | 5 | INE205C01021 |
| Renaissance Global Limited | 532923 | 25,000 | 2 | INE722H01024 |
| Sai Life Sciences Limited | 544306 | 429,000 | 1 | INE570L01029 |
Impact Justification
Routine listing of ESOP/ESOS shares with no lock-in period; dilution impact is minimal across affected stocks; standard administrative circular.